
Free Daily Podcast Summary
by ATTD on UNLOK
ATTD is the leading forum for the latest in diabetes research, technology, and clinical innovation. This podcast offers two types of content for healthcare professionals:* ATTD Conference Catch-up: AI-generated episodes with key insights from expert presentations & research discussions.* Curated Series: Human-led conversations such as ATTD Tech Connect (sponsored by Medtronic), and previously Long-Acting Insulin Uncovered (supported by Eli Lilly and Company) and CGM in Focus (supported by Dexcom).Whether you're a specialist, researcher, or industry leader, hit subscribe.
The most recent episodes — sign up to get AI-powered summaries of each one.
In this episode, host Bob Gabbay and his guest, Professor Simon Heller, discuss preventing and managing hypoglycemia, with a focus on the risks, recognition, and safety education.They discuss:Why hypoglycemia remains a major concern in insulin therapyKey risk factors to keep in mindClinical signs or patient-reported symptomsPrevention strategiesImportance of patient educationBalancing glycemic targets with hypoglycemia riskProf. Simon Heller is Professor of Clinical Diabetes at the University of Sheffield, and Director of Research & Development at Sheffield Teaching Hospitals, NHS Foundation Trust.Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
In this episode, host Bob Gabbay and his guest, Professor Tadej Battelino, Co-Chair of ATTD, discuss the latest technological innovations in diabetes, including delivery innovations, connected devices, titration support.They discuss:The new technologies making the biggest difference in insulin therapy todayThe role of smart pens, connected devices, and appsBiggest clinical impact - including adherence, titration and outcomesAccessibility of these tools in real-world practiceAdvisor role of AIThe promising future of technology in insulin therapy and a functional cureProfessor Tadej Battelino is Co-Chair of ATTD and Chair of International Diabetes Federation Europe.Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
In this episode, host Bob Gabbay and his guest, Dr George Grunberger, Chairman of the Grunberger Diabetes Institute, discuss best practice and guidance around basal insulin and GLP-1 combinations.They discuss:What exactly fixed-ratio combinations are and the problems they tackleIdentifying patient candidates and timelines for starting FRCsMeaningful benefits of FRCs compared with basal insulin aloneConcerns and limitations of FRCsHow guideline recommendations currently position FRCs in diabetes managementDr George Grunberger, Chairman of the Grunberger Diabetes Institute in Michigan. George is also Clinical Professor of Internal Medicine at Wayne State University School of Medicine, and Professor of Internal Medicine at Oakland University William Beaumont School of Medicine.Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
In this episode, host Bob Gabbay and his guest, Dr William Polonsky discuss safe and effective titration strategies, and the importance of collaborating with your patient.They discuss:The importance of titration in successful insulin therapyBarriers to titration, including patient self-managementHow clinicians can collaborate with patients in their titration journeyThe importance of language used by cliniciansPractical tips for simplifying titration in busy clinical settingsDr. Polonsky is President and Founder of the Behavioral Diabetes Institute, and Associate Clinical Professor in Psychiatry at the University of California.Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
In this episode, host Bob Gabbay and his guest, Dr Osama Hamdy, discuss how clinicians can identify patients for insulin initiation in Type 2 diabetes.They discuss:When clinicians should consider insulin for patients with T2DAddressing concerns of weight gain with insulinADA/EASD recommendationsBarriers to insulin therapy and Type 2 diabetesAdvice on communication with patientsDr Osama Hamdy is Associate Professor of Medicine at Harvard Medical School, and Director of the Obesity Clinical Program at the Joslin Diabetes Center.Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
In our new series, Insulin in Practice, host Dr Bob Gabbay looks at the principles of Basal Insulin Therapy in Type 2 Diabetes; its physiological role, pharmacodynamics, and current guideline-based use.He is joined by Dr Giulio Romeo.They discuss:The role of basal insulin in normal physiology and why it matters in Type 2 diabetesGoals of basal insulin therapyWhat makes new basal insulins differentCurrent guidelines and recommendations for basal insulin therapyAlternatives to basal insulin therapyTips for safe and effective initiation and titrationDr Giulio Romeo is Associate Medical Director of the Adult Diabetes Section at Joslin Diabetes Center, and Assistant Professor of Medicine, Harvard Medical School.Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
In this episode of ATTD 2026 Conference Catch-Up, we dive into Advancements in Type 1 Diabetes: From Pathogenesis to Therapy, featuring the latest breakthroughs in understanding and treating Type 1 diabetes, from viral triggers to novel treatment strategies. Join us as we summarize key takeaways from these thought-provoking presentations: Role of Viruses in Pathogenesis of Type 1 Diabetes – Dr. Teresa Rodriguez-Calvo Dendritic Cells for Treatment of Type 1 Diabetes – Dr. Jason Gaglia C-Peptide: A Marker for Functional Beta Cell Mass? – Prof. Chantal Mathieu This episode is an essential listen for endocrinologists, researchers, and healthcare professionals specializing in diabetes care, providing insights into the evolving landscape of Type 1 diabetes pathogenesis and the potential of dendritic cell therapies. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. https://attd.kenes.com
In this episode of ATTD 2026 Conference Catch-Up, we dive into ATTD AI School for Clinicians: From GenAI Foundations to Agentic CDSS Workflows - Safe, Practical Use in Diabetes Care, where we explore the application of AI technologies in diabetes care, focusing on safety, ethics, and practical use. Join us as we summarize key takeaways from these thought-provoking presentations: Welcome & Framing – Dr. Amit Dey & Prof. Peter Schwarz Foundations of AI & Gen-AI for Clinicians – Dr. Amit Dey Agentic AI & CDSS Workflows in Diabetes Care – Dr. Revital Nimri Ethics, EU AI Act & GDPR Essentials for Clinicians – Lucía Feito Allonca This episode is an essential listen for clinicians, diabetes specialists, and healthcare professionals seeking to understand the practical, safe, and ethical integration of GenAI and AI-driven clinical decision support systems (CDSS) in diabetes care. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. https://attd.kenes.com
ATTD is the leading forum for the latest in diabetes research, technology, and clinical innovation. This podcast offers two types of content for healthcare professionals:* ATTD Conference Catch-up: AI-generated episodes with key insights from expert presentations & research discussions.* Curated Series: Human-led conversations such as ATTD Tech Connect (sponsored by Medtronic), and previously Long-Acting Insulin Uncovered (supported by Eli Lilly and Company) and CGM in Focus (supported by Dexcom).Whether you're a specialist, researcher, or industry leader, hit subscribe.
AI-powered recaps with compact key takeaways, quotes, and insights.
Get key takeaways from ATTD: Advanced Technologies and Treatments for Diabetes in a 5-minute read.
Stay current on your favorite podcasts without falling behind.
It's a free AI-powered email that summarizes new episodes of ATTD: Advanced Technologies and Treatments for Diabetes as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by ATTD on UNLOK.
Absolutely! The free plan covers up to 3 podcasts. Upgrade to Pro for 15, or Premium for 50. Browse our full catalog at /podcasts.
ATTD: Advanced Technologies and Treatments for Diabetes publishes daily. Our AI generates a summary within hours of each new episode.
ATTD: Advanced Technologies and Treatments for Diabetes covers topics including Science, Life Sciences. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.